Sepsis and COVID-19: Two Paths to One Clinical Destination & SEP-1: Updates & Outcomes

Session Descriptions: 

This activity includes two sessions from the Sepsis Alliance Summit to meet the minimum time requirement for nursing CE credits.

Sepsis and COVID-19: Two Paths to One Clinical Destination

The most common complication in our patients with COVID-19 is sepsis. The two conditions are clinically and pathophysiologically  similar, but some differences have come to light and should inform all practitioners at the bedside. Join Barbara McLean, clinical practice expert in both Sepsis and COVID-19 in a frank discussion of the two paths of pathophysiology and the evolving critical bedside practice issues. 

SEP-1: Updates & Outcomes

During this session the two stewards of the SEP-1 measure and authors of a newly published study on its efficacy, Dr. Sean Townsend and Dr. Emanuel Rivers, discuss SEP-1, the latest updates, and what their new study of patient data reported by 3,241 hospitals to Medicare has found.  

These sessions were originally presented in September 2021 as part of the 2021 Sepsis Alliance Summit.

Target Audience

Nurses, Advanced Practice Providers, Physicians, Emergency Responders, Pharmacists, Medical Technologists, Respiratory Therapists, Physical/ Occupational Therapist, Social Workers, Mental Health Professionals, Students, IT Professionals, Sepsis Survivors, Advocates, and more! 

Learning Objectives

At the end of the presentation, the attendee should be able to: 

Sepsis and COVID-19: Two Paths to One Clinical Destination

  • Discuss the similarities and differences between Sepsis & COVID-19.
  • Understand the current critical bedside practice issues. 

SEP-1: Updates & Outcomes

  • Discuss the SEP-1 measures basic specifications.
  • Review recent SEP-1 updates.
  • Understand the results of the newly published study on SEP-1 outcomes. 
Course summary
Available credit: 
  • 1.75 Participation
  • 2.20 RN CE Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider Number CEP17068.
Course opens: 
06/15/2019
Course expires: 
12/31/2024

Sepsis and COVID-19: Two Paths to One Clinical Destination

Barbara McLean, MN, RN, CCRN, CCNS-BC, NP-BC, FCCM

Critical Care Program Specialist, Grady Health Systems

Barbara McLean has been in critical care practice for over 40 years. Currently, Barbara is the critical care program specialist at Grady Health Systems in Atlanta, GA. Ms. McLean is a member of many professional organizations including the American Association of Critical Care Nurses (AACN), the Society of Critical Care Medicine (SCCM) and the American Association of Surgery and Trauma. She has received multiple awards for her innovation, practice, and volunteerism in disaster management from the AACN and the SCCM (Society of Critical Care Medicine. Her webinars and podcasts regarding sepsis and other critical issues are highly touted. Over the last year and a half, she has been invited by many media outlets and beloved podcasters to discuss the critical practice issues for the covid 19 patient. She and a small group of her colleagues managed the very first patient with Covid admitted to the Grady Health System, subsequently she and her team trained over 1600 employees in the process of safe don and doff.   She and her team initiated several innovative methods of monitoring to decrease risk exposure and PPE consumption, while maintaining excellence in clinical practice. Barbara is an avid abstract reviewer, professor and mentor and has made more than 3000 presentations nationally and internationally based on her hemodynamic, sepsis and disaster expertise She has written many chapters and articles regarding hemodynamics, sepsis, ventilation, and oxygenation and continues her pursuit of knowledge and excellence in her daily practice.  Her research has been focused on blood flow and oxygenation and she continues to expand her knowledge every day in her local and international clinical practice. As an educator, provider and practitioner, Barbara is committed to patient care and safety; critical care practice, collegial communication, and evidence-based practice implementation at the bedside. Most importantly, every day of her personal and practice life are spent working towards improving care for patients and families. 

SEP-1: Updates & Outcomes

Sean R. Townsend, MD 

Vice President of Quality & Safety, California Pacific Medical Center (CPMC) San Francisco, California

Clinical Associate Professor of Medicine, University of California, San Francisco

Dr. Sean R. Townsend, M.D., is Vice President of Quality & Safety at California Pacific Medical Center (CPMC) in San Francisco, California. He is also Clinical Associate Professor of Medicine at University of California, San Francisco. Dr. Townsend is a practicing intensivist in the Division of Pulmonary and Critical Care at CPMC. Dr. Townsend led IHI's work on sepsis and served on the Surviving Sepsis Campaign (SSC) steering committee for many years. Dr. Townsend serves as measure steward for CMS’s national sepsis quality measure, SEP-1. 

Emanuel Rivers, MD, MPH

Attending Staff, Henry Ford Hospital

Clinical Professor, Wayne State University 

Dr. Rivers is an emergency medicine and critical care specialist. He is Vice Chairman and Director of Research in Emergency Medicine at Henry Ford Hospital in Detroit, MI. He is also a Clinical Professor at Wayne State University.  Dr. Rivers has been at the forefront of sepsis research and care for many years and has published several articles on sepsis diagnosis and management. His landmark paper, published in November 2001, supported and expanded early goal directed therapy. This improved early sepsis care to hospitalized patients who had signs of severe sepsis or septic shock worldwide. This approach also expanded the hospital landscape to include patients from the emergency department, general practice floors, and the critical care unit. Facilities across the country and around the world took notice of this concept and adapted it to suit their needs and save lives.  

Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 2.2 contact hours.

Other healthcare providers will receive a certificate of attendance for 1.75 contact hours.

Medical Disclaimer

The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare provider. Sepsis Alliance recommends users consult their physician or healthcare provider regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.

Available Credit

  • 1.75 Participation
  • 2.20 RN CE Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider Number CEP17068.
Please login or register to take this course.

 

This activity includes the following for each session:

  • Pre-test
  • Slides to download (Sepsis and COVID-19: Two Paths to One Clinical Destination only)
  • Pre-recorded webinar
  • Post-test
  • Evaluation

All components must be completed for each session to earn a certificate of attendance. This course can be completed at your convenience.